Technology of mammalian cell encapsulation

被引:443
作者
Uludag, H
De Vos, P
Tresco, PA
机构
[1] Univ Alberta, Dept Biomed Engn, Edmonton, AB T6G 2G3, Canada
[2] Univ Groningen Hosp, Surg Res Lab, NL-9713 BZ Groningen, Netherlands
[3] Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, Salt Lake City, UT 84112 USA
关键词
cells; encapsulation; micro; macro; encapsulation technology; alginate-polylysine capsules; thermoreversible gelation;
D O I
10.1016/S0169-409X(00)00053-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Entrapment of mammalian cells in physical membranes has been practiced since the early 1950s when it was originally introduced as a basic research tool. The method has since been developed based on the promise of its therapeutic usefulness in tissue transplantation. Encapsulation physically isolates a cell mass from an outside environment and aims to maintain normal cellular physiology within a desired permeability barrier. Numerous encapsulation techniques have been developed over the years. These techniques are generally classified as microencapsulation (involving small spherical vehicles and conformally coated tissues) and macroencapsulation (involving larger hat sheet and hollow-fiber membranes). This review is intended to summarize techniques of cell encapsulation as well as methods for evaluating the performance of encapsulated cells. The techniques reviewed include microencapsulation with polyelectrolyte complexation emphasizing alginate-polylysine capsules, thermoreversible gelation with agarose as a prototype system, interfacial precipitation and interfacial polymerization, as well as the technology of flat sheet and hollow fiber-based macroencapsulation. Four aspects of encapsulated cells that are critical for the success of the technology, namely the capsule permeability, mechanical properties, immune protection and biocompatibility, have been singled out and methods to evaluate these properties were summarized. Finally, speculations regarding future directions of cell encapsulation research and device development are included from the authors' perspective. (C) 2000 Published by Elsevier Science B.V.
引用
收藏
页码:29 / 64
页数:36
相关论文
共 279 条
[41]   INTERACTION OF ALGINATES AND PECTINS WITH CATIONIC POLYPEPTIDES [J].
BYSTRICKY, S ;
MALOVIKOVA, A ;
STICZAY, T .
CARBOHYDRATE POLYMERS, 1990, 13 (03) :283-294
[42]   INVERTED MICROCARRIERS FOR CELL-CULTURES MADE BY POLYMERIZATION OF SHELLS AROUND AGAROSE MICROSPHERES IN A NONCYTOTOXIC PROCEDURE [J].
CADIC, C ;
BAQUEY, C ;
DUPUY, B .
POLYMER JOURNAL, 1991, 23 (08) :933-937
[43]   The metabolism and pharmacokinetics of acrylamide: Implications for mechanisms of toxicity and human risk estimation [J].
Calleman, CJ .
DRUG METABOLISM REVIEWS, 1996, 28 (04) :527-590
[44]   HEMA/MMMA microcapsule implants in hemiparkinsonian rat brain:: biocompatibility assessment using [3H]PK11195 as a marker for gliosis [J].
Campioni, EG ;
Nobrega, JN ;
Sefton, MV .
BIOMATERIALS, 1998, 19 (7-9) :829-837
[45]   TNF AND IL-1 GENERATION BY HUMAN MONOCYTES IN RESPONSE TO BIOMATERIALS [J].
CARDONA, MA ;
SIMMONS, RL ;
KAPLAN, SS .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1992, 26 (07) :851-859
[46]   GROWTH OF RECOMBINANT FIBROBLASTS IN ALGINATE MICROCAPSULES [J].
CHANG, PL ;
HORTELANO, G ;
TSE, M ;
AWREY, DE .
BIOTECHNOLOGY AND BIOENGINEERING, 1994, 43 (10) :925-933
[47]   DELIVERY OF RECOMBINANT GENE-PRODUCTS WITH MICROENCAPSULATED CELLS IN-VIVO [J].
CHANG, PL ;
SHEN, N ;
WESTCOTT, AJ .
HUMAN GENE THERAPY, 1993, 4 (04) :433-440
[48]  
Chang T M, 1992, ASAIO J, V38, P128, DOI 10.1097/00002480-199204000-00013
[49]  
CHEIRER W, 1983, DEV BIOL STAND, V55, P155
[50]   ARTIFICIAL PANCREAS USING LIVING BETA CELLS - EFFECTS ON GLUCOSE HOMEOSTASIS IN DIABETIC RATS [J].
CHICK, WL ;
PERNA, JJ ;
LAURIS, V ;
LOW, D ;
GALLETTI, PM ;
PANOL, G ;
WHITTEMORE, AD ;
LIKE, AA ;
COLTON, CK ;
LYSAGHT, MJ .
SCIENCE, 1977, 197 (4305) :780-782